BHCM
ADAP

Boulder Hill Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Boulder Hill Capital Management’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-90,800
Closed -$143K – 3
2024
Q1 		$143K Buy
+90,800
New +$143K 0.06% 90